EX-99 2 b76399a1exv99.htm JUNE 2009 MONTHLY INSIGHT REPORT exv99
(IMAGE)
THE CHINA FUND, INC. (CHN)
(PICTURE)
The Martin Currie
Shanghai team
IN BRIEF
         
Net asset value per share
  US$ 22.68  
Market price
  US$ 20.98  
Premium/(discount)
    (7.50 %)
Fund size
  US$ 516.7 m
Source: State Street Bank and Trust Company
                 
At 30 June 2009           US$ returns  
    China Fund NAV     MSCI Golden Dragon*  
    %     %  
One month
    2.5       (0.8 )
Year to date
    30.4       36.4  
One year
    (11.9 )     (14.3 )
Three years %pa
    16.1       6.7  
 
Past performance is not a guide to future returns.
 
Source: State Street Bank and Trust Company. NAV performance.
 
*   Source for index data: MSCI.
MANAGER’S COMMENTARY
The main Chinese markets headed in different directions in June. Taiwan was the first into a summer correction, falling 8.5% on worries about demand for technology products and some impatience at the pace of signing the cross-straits memorandum of understanding for the financial industry. After early strength, Hong Kong snaked sideways, gaining just 0.9%. With ugly interims ahead, it is better to travel hopefully than arrive. Only the A-shares maintained their majestic progress, with the Shanghai 180 rising by 15.6%, based on huge credit growth; new loans worth 5.8 trillion yuan were made in the first half, more than in the whole of 2008 and already ahead of the government’s budget for the whole of 2009. With no one keen to build new factories at present, it is little wonder that money continues to flow into asset markets. It’s a confidence trick on a huge scale, but it seems to be working.
Retail sales continue to grow steadily (passenger car sales, for instance, grew by 37% year on year in May, up from 33% in April). One of the portfolio companies, the upmarket retailer Ports Design, reported particularly strong sales of store vouchers, used widely, apparently, to ‘reward’ government officials — an indication that the government is now, even more than before, the fount of most good things. Retail cash is clearly flowing into the asset markets (41 new mutual funds raised US$14 billion between January and May). The property market is heating up, but buyers remain sensitive on price. The government is using the period of deflation (CPI -1.4% in May) to raise prices: gasoline and diesel prices were increased by 10% and jet fuel by 25%; Shanghai recently raised water by 25%, with the promise of a further 21.7% rise in November 2010. We expect electricity prices to be next. We also expect inflation to return towards the year-end.
In the A-share market IPOs were revived, though the government has started cautiously with small-cap stocks that will not soak up too much liquidity. In Hong Kong, the clamouring for new issues has reached a pitch not seen for more than a year. The Fund received a miniscule allocation for the herbal-shampoo-maker Bawang (420 times oversubscribed).

 


 

INVESTMENT STRATEGY
The Fund is now 98% invested with holdings in 68 companies. Of the portfolio, 17.5% is in direct investments. This will fall slightly after the month-end, as we put the investment in Wuxi Paiho back to the company, which has repaid our initial investment plus an 8% p.a. coupon.
Worried by the outlook for capital goods, we sold the long-term holding Zhenhua Port Machinery in June. We also exited less successful technology investments, TPV and Yorkey, into improved liquidity. In their place we bought China Pharmaceutical, the prospects for which have brightened after a change of ownership. Ahead of the revival of IPOs in the A-share market, we bought the leading domestic broker CITIC Securities, as well as Minsheng Bank. We added to existing holdings in Far East Energy (now producing coal-bed methane from a high-permeability field in Shanxi) and the convenience-store operator Taiwan Familymart, which is expanding its presence in China.
Chris Ruffle, Martin Currie Inc*
 
*   Martin Currie Ltd and Heartland Capital Management Ltd (HCML) have established MC China Ltd (MCCL), as a joint venture company, to provide investment management or investment advisory services to the range of China investment products managed by Martin Currie.
MCCL has appointed Martin Currie Investment Management Ltd (MCIM), or its affiliates, as investment manager of Martin Currie’s China investment products. HCML has seconded both Chris Ruffle and Shifeng Ke to MCIM, or its affiliates, on a full time basis with the same roles and responsibilities as if they were full time employees.

 


 

30 June 2009
FUND DETAILS
         
Market cap
  US$ 478.0m
Shares outstanding
    22,781,762  
Exchange listed
  NYSE  
Listing date
  July 10, 1992  
Listed and direct investment manager
  Martin Currie Inc  
Source: State Street Bank and Trust Company.
SECTOR ALLOCATION
                 
    The China   MSCI Golden
    Fund, Inc   Dragon
Consumer discretionary
    24.0 %     4.4 %
Consumer staples
    18.4 %     2.1 %
Healthcare
    13.7 %      
Financials
    12.8 %     37.4 %
Industrials
    11.4 %     8.0 %
Information technology
    7.4 %     19.1 %
Energy
    5.0 %     8.9 %
Materials
    2.6 %     6.2 %
Utilities
    1.7 %     4.2 %
Telecommunications
    1.0 %     9.6 %
Other assets & liabilities
    2.0 %      
Source: State Street Bank and Trust Company. Source for index data: MSCI
ASSET ALLOCATION
(PIE CHART)
Source: State Street Bank and Trust Company
     
PERFORMANCE   (US$ RETURNS)
                 
    NAV     Market price  
    %     %  
One month
    2.5       (3.8 )
Year to date
    30.4       26.8  
Three years %pa
    16.1       14.6  
Past performance is not a guide to future returns.
Three year returns are annualized.
Source: State Street Bank and Trust Company
15 LARGEST HOLDINGS (44.5%)
                 
Queenbury Investment (Huiyan)
  Consumer discretionary     7.9 %
Ugent Holdings
  Industrials     4.4 %
Shandong Weigao Group
  Healthcare     3.9 %
CITIC Securities
  Financials     3.8 %
Wumart Stores
  Consumer staples     3.6 %
Far Eastern Department Stores
  Consumer discretionary     3.5 %
Shenzhen Agricultural Products
  Consumer staples     2.2 %
China Shineway Pharmaceutical
  Healthcare     2.2 %
Ruentex Development
  Financials     2.1 %
Ports Design
  Information technology     2.0 %
China Huiyuan Juice
  Consumer staples     1.9 %
China Medical System
  Healthcare     1.8 %
China Fishery Group
  Consumer staples     1.8 %
Uni-President Enterprises
  Consumer staples     1.7 %
Fushan International Energy
  Energy     1.7 %
 
DIRECT INVESTMENTS (17.5%)
           
 
Queenbury Investment (Huiyan)
  Consumer discretionary     7.9 %
Ugent Holdings
  Industrials     4.4 %
Qingdao Bright Moon
  Industrials     1.6 %
HAND Enterprise Solutions
  Information technology     1.6 %
Highlight Tech
  Industrials     1.3 %
China Silicon (Series A Preferred)
  Information technology     0.7 %
China Silicon (Common Stock)
  Information technology     0.0 %
China Silicon (Warrants)
  Information technology     0.0 %
TECO Optronics
  Information technology     0.0 %
Source: State Street Bank and Trust Company.
     
FUND PERFORMANCE (BASED ON NET ASSET VALUE)   (US$ RETURNS)
                                                         
    One     Three     Calendar     One     Three     Five     Since  
    month     months     year to date     year     years     years     launch  
    %     %     %     %     % pa     % pa     % pa  
The China Fund, Inc.
    2.5       32.2       30.4       (11.9 )     16.1       18.8       10.8  
MSCI Golden Dragon
    (0.8 )     32.4       36.4       (14.3 )     6.7       11.5       8.6  
Hang Seng China Enterprise
    5.2       35.8       38.9       (7.4 )     17.4       20.8       21.6  
Shanghai Stock Exchange 180
    15.6       27.1       74.6       13.3       37.6       27.7       n/a  
Past performance is not a guide to future returns.
Source: State Street Bank and Trust Company. Launch date 10 July 1992. Three year, five year and since launch returns are all annualized.
Source for index data: MSCI for the MSCI Golden Dragon and Copyright 2009 Bloomberg LP for the Hang Seng China Enterprise and the Shanghai Stock Exchange 180. For a full description of each index please see the index descriptions section.

 


 

PERFORMANCE IN PERSPECTIVE
(LINE GRAPH)
Past performance is not a guide to future returns.
Source: Martin Currie Inc as at 30 June 2009.
THE CHINA FUND INC. PREMIUM/DISCOUNT
(LINE GRAPH)
Past performance is not a guide to future returns.
Source: Martin Currie Inc as at 30 June 2009.
10 YEAR DIVIDEND HISTORY CHART
(BAR GRAPH)
                                                                                 
Total
    0.11       0.00       0.13       0.21       1.78       3.58       2.51       4.01       12.12       5.82  
Income
    0.11       0.00       0.13       0.06       0.07       0.20       0.22       0.30       0.28       0.48  
Long-term capital
    0.00       0.00       0.00       0.00       0.67       3.27       2.29       2.73       9.00       5.34  
Short-term capital
    0.00       0.00       0.00       0.15       1.04       0.11       0.00       0.98       2.84       0.00  
Past performance is not a guide to future returns.
Source: State Street Bank and Trust Company.

 


 

30 JUNE 2009
                                         
Sector   Company (BBG ticker)     Price     Holding     Value US$     % of portfolio  
Hong Kong
                                    21.5 %
China Shineway Pharmaceutical
  2877 HK   HK$ 7.8       11,184,000       11,328,237       2.2 %
Ports Design
  589 HK   HK$ 18.2       4,549,500       10,589,994       2.0 %
China Huiyuan Juice
  1886 HK   HK$ 5.5       14,055,000       9,956,316       1.9 %
Fushan International Energy
  639 HK   HK$ 4.3       16,044,000       8,860,371       1.7 %
Chaoda Modern Agriculture
  682 HK   HK$ 4.6       14,885,357       8,777,502       1.7 %
Xinao Gas
  2688 HK   HK$ 13.2       5,084,000       8,737,863       1.7 %
Natural Beauty Bio-Technology
  157 HK   HK$ 1.3       48,680,000       8,102,812       1.6 %
FU JI Food & Catering Services
  1175 HK   HK$ 6.5       8,689,000       7,242,655       1.4 %
Shangri-La Asia
  0069 HK   HK$ 11.5       4,755,555       6,995,223       1.4 %
Golden Meditech
  8180 HK   HK$ 1.3       35,040,000       6,148,915       1.2 %
Intime Department Store Group
  1833 HK   HK$ 3.4       12,568,629       5,513,944       1.1 %
Anta Sports
  2020 HK   HK$ 9.7       3,883,000       4,809,879       0.9 %
Huabao International
  336 HK   HK$ 7.5       4,255,000       4,117,715       0.8 %
TPV Technology
  903 HK   HK$ 3.5       8,854,000       3,941,433       0.8 %
Yorkey Optical International
  2788 HK   HK$ 1.4       10,694,926       1,918,174       0.4 %
Bawang International
  1338 HK   HK$ 2.4       858,600       263,672       0.0 %
 
                                       
Singapore
                                    4.5 %
China Fishery Group
  CFG SP   SG$ 1.0       13,255,000       9,336,441       1.8 %
Hsu Fu Chi International
  HFCI SP   SG$ 1.2       9,484,000       8,055,604       1.6 %
Financial One Corp
  FIN SP   SG$ 0.3       12,030,000       2,284,545       0.4 %
CDW
  CDW SP   SG$ 0.1       59,708,000       2,267,758       0.4 %
China Milk Products Group
  CMILK SP   SG$ 0.4       4,923,000       1,359,851       0.3 %
 
                                       
Hong Kong ‘H’ shares
                                    10.4 %
Shandong Weigao Group
  8199 HK   HK$ 19.9       7,808,000       20,048,800       3.9 %
Wumart Stores
  995 HK   HK$ 9.7       14,888,000       18,537,842       3.6 %
Zijin Mining
  2899 HK   HK$ 7.0       7,214,000       6,534,445       1.3 %
ZTE Corp
  763 HK   HK$ 26.9       1,461,926       5,074,265       1.0 %
China Pharmaceutical Group
  1093 HK   HK$ 4.0       6,854,000       3,519,838       0.6 %
 
                                       
Taiwan
                                    18.8 %
Far Eastern Department Stores
  2903 TT   NT$ 32.3       18,511,584       18,195,629       3.5 %
Ruentex Development
  9945 TT   NT$ 27.6       12,694,000       10,678,281       2.1 %
Uni-President Enterprises
  1216 TT   NT$ 33.8       8,728,581       8,991,955       1.7 %
Taiwan Secom
  9917 TT   NT$ 50.7       4,738,000       7,321,444       1.4 %
Yuanta Financial
  2885 TT   NT$ 22.1       10,520,593       7,086,410       1.4 %
FamilyMart
  5903 TT   NT$ 54.3       4,257,652       7,046,343       1.4 %
Lien Hwa Industrial
  1229 TT   NT$ 14.4       15,919,692       6,962,742       1.3 %
China Metal Products
  1532 TT   NT$ 25.0       9,019,881       6,872,814       1.3 %
WPG Holdings
  3702 TT   NT$ 32.6       6,320,000       6,269,918       1.2 %
HTC Corp
  2498 TT   NT$ 464.0       438,000       6,194,209       1.2 %
Synnex Technology
  2347 TT   NT$ 53.5       2,553,855       4,164,317       0.8 %
KGI Securities
  6008 TT   NT$ 15.0       8,800,000       4,023,164       0.8 %
Merry Electronics
  2439 TT   NT$ 31.7       3,584,340       3,463,077       0.7 %
 
                                       
United Kingdom
                                    1.8 %
China Medical System Holdings
  CMSH LN   £ 1.61       3,623,188       9,565,445       1.8 %
 
                                       
United States
                                    6.1 %
WuXi PharmaTech Cayman
  WX US   US$ 9.4       800,790       7,559,457       1.5 %
Far East Energy
  FEEC US   US$ 0.4       13,957,259       5,373,545       1.0 %
Mindray Medical International
  MR US   US$ 27.9       191,700       5,352,264       1.0 %
New Oriental Education
  EDU US   US$ 67.4       73,400       4,944,224       1.0 %
Sina Corp
  SINA US   US$ 29.5       162,700       4,796,396       0.9 %
The9
  CMED US   US$ 10.2       352,300       3,575,845       0.7 %
 
                                       
Equity linked securities (‘A’ shares)
                                    17.4 %
CITIC Securities
          US$ 4.1       4,720,200       19,528,430       3.8 %
Shenzhen Agricultural
          US$ 1.7       6,800,000       11,328,855       2.2 %
China Yangtze Power
          US$ 2.0       4,169,077       8,410,542       1.6 %
Wuliangye Yibin
          US$ 2.9       2,857,007       8,251,036       1.6 %
Suning Appliance
          US$ 2.4       2,874,013       6,759,678       1.3 %
Zhejiang Guyuelongshan
          US$ 1.1       6,124,000       6,589,571       1.3 %
Shanghai Yuyuan Tourist Board
          US$ 2.5       238,502,000       6,033,516       1.2 %
Daqin Railway
          US$ 1.6       3,807,000       5,902,198       1.1 %
China Minsheng Banking
          US$ 1.2       4,758,300       5,517,111       1.1 %
Ping An Insurance
          HK  52.5       614,500       4,158,751       0.8 %
Shanghai International Airport
          US$ 2.2       1,816,700       4,083,942       0.8 %
Dalian Zhangzidao Fishery
          US$ 3.0       1,100,565       3,327,008       0.6 %

 


 

                                         
Sector   Company (BBG ticker)     Price     Holding     Value US$     % of portfolio  
Direct
                                    17.5 %
Queenbury Investment (Huiyan)
          US$ 90345.0       450       40,655,250       7.9 %
Ugent Holdings
          HK$ 100.0       177,000,000       22,838,562       4.4 %
Qingdao Bright Moon
          US$ 0.3       31,827,172       8,275,065       1.6 %
HAND Enterprise Solutions
          US$ 16.4       500,000       8,200,000       1.6 %
Highlight Tech
          US$ 2.1       3,366,893       6,902,131       1.3 %
China Silicon (Series A Preferred)
          US$ 133.0       27,418       3,646,594       0.7 %
China Silicon
                  293,068              
China Silicon (Warrants)
                  685,450              
teco Optronics
                  1,861,710              
 
                                       
Other assets & liabilities
                            10,067,523       2.0 %
INDEX DESCRIPTIONS
MSCI Golden Dragon Index
The MSCI Golden Dragon is a free float-adjusted market capitalization index that is designed to measure equity market performance in the China region. As of May 2005 the MSCI Golden Dragon Index consisted of the following country indices: China, Hong Kong and Taiwan.
Hang Seng China Enterprise Index
The Hang Seng China Enterprise Index is a capitalization-weighted index comprised of state-owned Chinese companies (H-shares) listed on the Hong Kong Stock Exchange and included in Hans Seng Mainland China index.
Shanghai Stock Exchange 180 Index
The Shanghai Stock Exchange 180 ‘A’ Share Index is a capitalization-weighted index. The index tracks the daily price performance of the 180 most representative ‘A’ share stocks listed on the Shanghai Stock Exchange.
OBJECTIVE
The investment objective of the Fund is to achieve long term capital appreciation. The Fund seeks to achieve its objective through investment in the equity securities of companies and other entities with significant assets, investments, production activities, trading or other business interests in China or which derive a significant part of their revenue from China.
The Board of Directors of the Fund has adopted an operating policy of the Fund, effective 30 June 2001, that the Fund will invest at least 80% of its assets in China companies. For this purpose, ‘China companies’ are (i) companies for which the principal securities trading market is in China; (ii) companies for which the principal securities trading market is outside of China or in companies organized outside of China, that in both cases derive at least 50% of their revenues from goods or services sold or produced, or have a least 50% of their assets in China; or (iii) companies organized in China. Under the policy, China will mean the People’s Republic of China, including Hong Kong, and Taiwan. The Fund will provide its stockholders with at least 60 days’ prior notice of any change to the policy described above.
The Fund is subject to the Investment Company Act of 1940 which limits the means in which it can access the ‘A’ share market. The Fund will continue to seek the most efficient way in which to increase its ‘A’ share exposure ensuring ongoing compliance with its legal and regulatory obligations.
CONTACTS
The China Fund, Inc.
c/o State Street Bank and Trust Company
2 Avenue de Lafayette
PO Box 5049
Boston, MA 02206-5049
Tel: (1) 888 CHN-CALL (246 2255)
www.chinafundinc.com

 


 

Important information: This document is issued and approved by Martin Currie Inc (MC Inc), as investment adviser of The China Fund Inc (the Fund). MC Inc is authorised and regulated by the Financial Services Authority (FSA) and incorporated under limited liability in New York, USA. Registered in Scotland (No BR2575), registered address Saltire Court, 20 Castle Terrace, Edinburgh, EH1 2ES. Information herein is believed to be reliable but has not been verified by MC Inc. MC Inc makes no representation or warranty and does not accept any responsibility in relation to such information or for opinion or conclusion which the reader may draw from the newsletter.
Martin Currie Ltd and Heartland Capital Management Ltd (HCML) have established MC China Ltd (MCCL), as a joint venture company, to provide investment management or investment advisory services to our China product. MCCL has appointed Martin Currie Investment Management Ltd (MCIM), or its affiliates, as investment manager of our China funds. HMCL has seconded both Chris Ruffle and Shifeng Ke to MCIM or its affiliates on a full time basis with the same roles and responsibilities as if they were full time employees.
The Fund is classified as a ‘non-diversified’ investment company under the US Investment Company Act of 1940 as amended. It meets the criteria of a closed ended US mutual fund and its shares are listed on the New York Stock Exchange. MC Inc has been appointed investment adviser to the Fund.
Investors are advised that they will not generally benefit from the rules and regulations of the United Kingdom Financial Services and Markets Act 2000 and the FSA for the protection of investors, nor benefit from the United Kingdom Financial Services Compensation Scheme, nor have access to the Financial Services Ombudsman in the event of a dispute. Investors will also have no rights of cancellation under the FSA’s Conduct of Business Sourcebook of the United Kingdom.
This newsletter does not constitute an offer of shares. MC Inc, its ultimate and intermediate holding companies, subsidiaries, affiliates, clients, directors or staff may, at any time, have a position in the market referred to herein, and may buy or sell securities, currencies, or any other financial instruments in such markets. The information or opinion expressed in this newsletter should not be construed to be a recommendation to buy or sell the securities, commodities, currencies or financial instruments referred to herein.
The information provided in this report should not be considered a recommendation to purchase or sell any particular security. There is no assurance that any securities discussed herein will remain in an account’s portfolio at the time you receive this report or that securities sold have not been repurchased.
It should not be assumed that any of the securities transactions or holdings discussed here were or will prove to be profitable, or that the investment recommendations or decisions we make in the future will be profitable or will equal the investment performance of the securities discussed herein.
Investing in the Fund involves certain considerations in addition to the risks normally associated with making investments in securities. The value of the shares issued by the Fund, and the income from them, may go down as well as up and there can be no assurance that upon sale, or otherwise, investors will receive back the amount originally invested. There can be no assurance that you will receive comparable performance returns, or that investments will reflect the performance of the stock examples contained in this document. Movements in foreign exchange rates may have a separate effect, unfavorable as well as favorable, on the gain or loss otherwise experienced on an investment. Past performance is not a guide to future returns. Accordingly, the Fund is only suitable for investment by investors who are able and willing to withstand the total loss of their investment. In particular, prospective investors should consider the following risks:
®   The companies quoted on Greater Chinese stock exchanges are exposed to the risks of political, social and religious instability, expropriation of assets or nationalisation, rapid rates of inflation, high interest rates, currency depreciation and fluctuations and changes in taxation, which may affect income and the value of investments.
 
®   At present, the securities market and the regulatory framework for the securities industry in China is at an early stage of development. The China Securities Regulatory Commission (CSRC) is responsible for supervising the national securities markets and producing relevant regulations. The Investment Regulations, under which the Fund invests in the People’s Republic of China (PRC) and which regulate repatriation and currency conversion, are new. The Investment Regulations give CSRC and State Administration of Foreign Exchange (SAFE) wide discretions and there is no precedent or certainty as to how these discretions might be exercised, either now or in the future. The Fund may, from time to time, obtain access to the securities markets in China via Access Products. Such products carry additional risk and may be less liquid than the underlying securities which they represent.
 
®   During the past 15 years, the PRC government has been reforming the economic and political systems of the PRC, and these reforms are expected to continue, as evidenced by the recently announced changes. The Fund’s operations and financial results could be adversely affected by adjustments in the PRC’s state plans, political, economic and social conditions, changes in the policies of the PRC government such as changes in laws and regulations (or the interpretation thereof), measures which may be introduced to control inflation, changes in the rate or method of taxation, imposition of additional restrictions on currency conversion and the imposition of additional import restrictions.
 
®   PRC’s disclosure and regulatory standards are in many respects less stringent than standards in certain Organisation for Economic Co-operation and Development (OECD) countries, and there may be less publicly available or less reliable information about PRC companies than is regularly published by or about companies from OECD countries.
 
®   The Shanghai Stock Exchange and Shenzhen Stock Exchange have lower trading volumes than most OECD exchanges and the market capitalisations of listed companies are small compared to those on more developed exchanges in developed markets. The listed equity securities of many companies in the PRC are accordingly materially less liquid, subject to greater dealing spreads and experience materially greater volatility than those of OECD countries. These factors could negatively affect the Fund’s NAV.
 
®   The Fund invests primarily in securities denominated in other currencies but its NAV will be quoted in US dollars. Accordingly, a change in the value of such securities against US dollars will result in a corresponding change in the US dollar NAV.
 
®   The marketability of quoted shares may be limited due to foreign investment restrictions, wide dealing spreads, exchange controls, foreign ownership restrictions, the restricted opening of stock exchanges and a narrow range of investors. Trading volume may be lower than on more developed stockmarkets, and equities are less liquid. Volatility of prices can also be greater than in more developed stockmarkets. The infrastructure for clearing, settlement and registration on the primary and secondary markets may be underdeveloped. Under certain circumstances, there may be delays in settling transactions in some of the markets.
Martin Currie Inc, registered in Scotland (no BR2575)
Registered office: Saltire Court, 20 Castle Terrace, Edinburgh EH11 2ES Tel: 44 (0) 131 229 5252 Fax: 44 (0) 131 228 5959 www.martincurrie.com/china
North American office: 1350 Avenue of the Americas, Suite 3010, New York, NY 10019, USA Tel: (1) 212 258 1900 Fax: (1) 212 258 1919
Authorised and registered by the Financial Services Authority and incorporated with limited liability in New York, USA.
Please note: calls to the above numbers may be recorded.